He Xing-xiang, Yang Jun, Zheng Xue-ling, Ding Yuan-wei, Shen Qing-yan, Liu Wei, Zhao Ying-heng
Department of Gastroenterology, the Second Affiliated Hospital of Guangzhou Medical College, Guangzhou 510260, China.
Chin Med J (Engl). 2005 Jul 20;118(14):1201-5.
Macrophage migration inhibitory factor (MIF) plays a pivotal role in inflammatory and immune-mediated diseases. However, its molecular function and role in gastrointestinal diseases has rarely been studied and thus warrants an in-depth investigation. This study was designed and conducted to determine MIF expression in Helicobacter pylori (H. pylori)-induced gastritis and the effect of H. pylori on MIF expression in monocytes in vitro.
Gastric specimens of 62 patients with chronic gastritis were obtained through endoscopic biopsies. Both gastric antrum and body were examined for histopathologic changes. Positive H. pylori was determined through rapid urease test and histopathological examination. A patient was classified as H. pylori positive if both tests showed positive results. The updated Sydney System was employed to assess the severity and activity of gastric inflammation. Double immunoassaying for MIF/T-cells (CD45RO) and MIF/macrophage (KP1), as well as in situ hybridization for the expression of MIF mRNA were used for the current analysis. THP-1, a monocyte cell line, was co-incubated with H. pylori strains (ATCC26695) and subsequently examined for the expression of MIF protein and mRNA by enzyme linked immunosorbent assay and retrospective transcription-polymerase chain reaction, respectively.
Among 62 patients with chronic gastritis, significant increase in total T-cells, MIF+ T-cells, total macrophages, MIF+ macrophages and MIF mRNA+ cells was observed in 42 H. pylori positive patients compared to H. pylori negative patients. Moreover, the increase of the MIF mRNA+ cells was highly correlated with the severity of the disease (number of MIF mRNA+ cells/mm(2), mild: 2834 +/- 382, moderate: 3569 +/- 123, severe: 3881 +/- 118, P < 0.01). In vitro results showed that the expression of MIF protein and mRNA in monocytes was significantly increased after incubation with H. pylori strains.
Overexpression of MIF is common in H. pylori-induced gastric inflammation, which suggests MIF may play an important role in the initiation and development of this disease.
巨噬细胞移动抑制因子(MIF)在炎症和免疫介导的疾病中起关键作用。然而,其分子功能以及在胃肠道疾病中的作用鲜有研究,因此值得深入探究。本研究旨在确定巨噬细胞移动抑制因子(MIF)在幽门螺杆菌(H. pylori)诱导的胃炎中的表达情况以及幽门螺杆菌对体外单核细胞中MIF表达的影响。
通过内镜活检获取62例慢性胃炎患者的胃标本。对胃窦和胃体进行组织病理学变化检查。通过快速尿素酶试验和组织病理学检查确定幽门螺杆菌阳性。若两项检查结果均为阳性,则患者被分类为幽门螺杆菌阳性。采用更新后的悉尼系统评估胃炎症的严重程度和活动度。本分析采用MIF/T细胞(CD45RO)和MIF/巨噬细胞(KP1)的双重免疫测定以及MIF mRNA表达的原位杂交。单核细胞系THP-1与幽门螺杆菌菌株(ATCC26695)共同孵育,随后分别通过酶联免疫吸附测定和逆转录聚合酶链反应检测MIF蛋白和mRNA的表达。
在62例慢性胃炎患者中,与幽门螺杆菌阴性患者相比,42例幽门螺杆菌阳性患者的总T细胞、MIF + T细胞、总巨噬细胞、MIF +巨噬细胞和MIF mRNA +细胞显著增加。此外,MIF mRNA +细胞的增加与疾病严重程度高度相关(MIF mRNA +细胞数/mm(2),轻度:2834±382,中度:3569±123,重度:3881±118,P < 0.01)。体外结果显示,与幽门螺杆菌菌株孵育后,单核细胞中MIF蛋白和mRNA的表达显著增加。
MIF的过表达在幽门螺杆菌诱导的胃炎症中很常见,这表明MIF可能在该疾病的发生和发展中起重要作用。